Journey Medical Corporation - Common Stock (DERM)
5.2800
0.00 (0.00%)
Journey Medical Corp is a healthcare company focused on the development and commercialization of innovative dermatological products
The company aims to address various skin conditions and enhance patient care through a diverse portfolio of prescription medications. By leveraging advanced research and clinical expertise, Journey Medical strives to improve treatment options for dermatological diseases while working collaboratively with healthcare providers to ensure the effective delivery of their products to patients.
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 29, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/04/A-Different-Picture.jpeg?width=1200&height=800&fit=crop)
Journey Medical (NASDAQDERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea.
Via Benzinga · November 4, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
DERM stock results show that Journey Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
DERM stock results show that Journey Medical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/10/Movers.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 10, 2024
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.
Via InvestorPlace · April 11, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/28/image30.jpeg?width=1200&height=800&fit=crop)
The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · March 28, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/26/image37.jpeg?width=1200&height=800&fit=crop)
Shares of Westport Fuel Systems Inc. (NASDAQWPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Via Benzinga · March 26, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · March 26, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
DERM stock results show that Journey Medical beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 21, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Creative Realities (NASDAQCREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via Benzinga · March 21, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 5, 2024
![](https://cdn.benzinga.com/files/images/story/2023/12/26/image42.jpg?width=1200&height=800&fit=crop)
Shares of RayzeBio, Inc. (NASDAQRYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.
Via Benzinga · December 26, 2023
![](https://cdn.benzinga.com/files/images/story/2023/11/29/patterson_companies_-_logo.jpg?width=1200&height=800&fit=crop)
Shares of Patterson Companies, Inc. (NASDAQPDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.
Via Benzinga · November 29, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 29, 2023
![](https://cdn.benzinga.com/files/images/story/2023/10/11/sportsmans_warehouse_-_logo.jpg?width=1200&height=800&fit=crop)
The Dow Jones closed higher by more than 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · October 11, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 7, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 6, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 22, 2023